FAQ-Post Translational Modification

FAQ-Post Translational Modification


Negotiable Min Order Quantity Unit

Required Quantity
Place of Origin
U.S.A
Payment Terms
Negotiable
Production method
Negotiable
Shipping / Lead Time
Negotiable / Negotiable
Keyword
faq-post translational modification
Category
Pharmaceutical Intermediates

Creative Proteomics

Membership
BIZ
Country / Year Established
U.S.A U.S.A / 2008
Business type
Manufacturer
Verified Certificate

9

Product name FAQ-Post Translational Modification Certification -
Category Pharmaceutical Intermediates Ingredients -
Keyword faq-post translational modification Unit Size -
Brand name - Unit Weigh -
origin U.S.A Stock -
Supply type - HS code -

Product Information

 

  1. What are the concerns about mapping a phosphorylation site in my protein?

    You will have two major concerns:
    Coverage: Can the mass spectrometry technique(s) deliver high sequence coverage? With higher coverage, there is a greater statistical chance to detect and identify the peptide containing a modification group.
    Occupancy of the modification site: What percent of the protein preparation is modified? If it is low, then the chance of detecting the modified peptide decreases. If the occupancy is high (>30%), then this works in the favor of identifying a modification site.

  2. How can coverage be increased for mapping phosphorylation or methylation sites?

    First, note that, due to its unique sequences, every protein has a different potential to be mapped at high sequence coverage.
    Coverage for all proteins increases by:
    a)    Starting with a higher amount of protein (>5 μg of protein is desirable) for MS analysis
    b)    Making sure that the protein is pure
    c)    Using multiple MS instruments/techniques for analysis will increase coverage
    d)    Enriching the phosphopeptides using a TiO2 column

 

B2B Trade

Price (FOB) Negotiable transportation -
MOQ Negotiable Leadtime Negotiable
Payment Options Negotiable Shipping time Negotiable

Creative Proteomics

Country / Year Established
U.S.A U.S.A / 2008
Membership
BIZ
Business type
Manufacturer

9

President
Dr.Chen
Address
45-1 Ramsey Road
Product Category
Other Pharmaceutical Chemicals
Year Established
2008
No. of Total Employees
101-500
Company introduction
<p> 

Creative Proteomics is the proteomics division of CD Inc, an integrated CRO company that provides a full range of drug development services, including Molecular Biology, Biochemistry, Systems Biology, Organic Chemistry, Genomics, Bioinformatics, Structural Biology, Preclinical and Clinical studies.

Creative Proteomics specializes in a full range of services to support various proteome-related researches from identification of single proteins to large-scale proteomic studies. We have one of the most advanced proteomics platforms in the world and our staff scientists are experienced proteomics professionals. Our proteome analysis platform provides protein separation, characterization, identification and quantification services, featured with high throughput and super-sensitivity. In addition, analyses of protein post-translational modifications such as phosphorylation and glycosylation are available.

 

Main Markets

U.S.A U.S.A

Main Product

Related Products

Other buyers also search

Membership Grade

BUYER

Biz Pro VIP

SELLER

Biz Pro VIP
팝업닫기
Live Chat A new message arrives
from a business partner.

No Data

  • There is no data to load
  • Check out the My TK > My Inquiries list.
  • After agreeing to the use of the Live Chat service, the list is printed only when there is at least one history of receiving or sending a Live Chat request.

If you have not yet agreed to use the Live Chat service,

You can use the Live Chat freely after agreeing to the use of the Live Chat service.

View more
View more